News

Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
While BMO Capital Markets said that zimislecel is “highly encouraging” for type 1 diabetes, questions regarding its target ...
A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...
Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) American Diabetes Association (ADA) 85th Scientific Sessions Conference June 20, 2025 8:15 PM ET James Markmann - Corporate Participant Michael ...
Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...
Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...
Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented ...